Stock comparison
AMGEN INC is 97.1x more valuable than RECURSION PHARMACEUTICALS, INC. by market capitalization ($196.28 B vs $2.02 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 97.1x more valuable than RECURSION PHARMACEUTICALS, INC. by market capitalization ($196.28 B vs $2.02 B).
Market value leader
AMGN
AMGEN INC is 97.1x more valuable than RECURSION PHARMACEUTICALS, INC. by market capitalization ($196.28 B vs $2.02 B).
Revenue leader
AMGN
RXRX: $74.68M vs AMGN: $36.75B.
Profit leader
AMGN
RXRX: -$644.76M vs AMGN: $7.71B.
Margin leader
AMGN
RXRX: -863.4% vs AMGN: 21.0% net margin.
| Metric | RXRX | AMGN |
|---|---|---|
| Market cap | $2.02 B | $196.28 B |
| US-listed rank | #2130 | #75 |
| Revenue (latest FY) | $74.68M | $36.75B |
| Net income (latest FY) | -$644.76M | $7.71B |
| Net margin | -863.4% | 21.0% |
| P/E (trailing FY) | - | 25.5x |
| SEC filings | 908 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 97.1x more valuable than RECURSION PHARMACEUTICALS, INC. by market capitalization ($196.28 B vs $2.02 B).
In their latest fiscal years, RECURSION PHARMACEUTICALS, INC. reported $74.68M in revenue while AMGEN INC reported $36.75B.
Full pages: RECURSION PHARMACEUTICALS, INC. and AMGEN INC, or browse the full rankings.